Publications:

A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Plos One

Lynch, Christopher J CJ; Cawte, Adam D AD; Millar, Carolyn M CM; Rueda, David D; Lane, David A DA

Publication Date: 2017

Variant appearance in text: VWF: M1528V

PubMed Link: 29186156

Variant Present in the following documents:

• Main text
• pone.0188405.pdf

View BVdb publication page

Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF.

Blood

Lynch, Christopher J CJ; Lane, David A DA; Luken, Brenda M BM

Publication Date: 2014-04-17

Variant appearance in text: VWF: M1528V

PubMed Link: 24558203

Variant Present in the following documents:

• Main text

View BVdb publication page

Molecular mechanisms of disease-causing missense mutations.

Journal Of Molecular Biology

Stefl, Shannon S; Nishi, Hafumi H; Petukh, Marharyta M; Panchenko, Anna R AR; Alexov, Emil E

Publication Date: 2013-11-01

Variant appearance in text: VWF: M1528V

PubMed Link: 23871686

Variant Present in the following documents:

• Main text

View BVdb publication page

Mechanisms by which von Willebrand disease mutations destabilize the A2 domain.

The Journal Of Biological Chemistry

Xu, Amy J AJ; Springer, Timothy A TA

Publication Date: 2013-03-01

Variant appearance in text: VWF: M1528V

PubMed Link: 23322777

Variant Present in the following documents:

• Main text

View BVdb publication page

Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Clinics In Laboratory Medicine

Torres, Richard R; Fedoriw, Yuri Y

Publication Date: 2009-06

Variant appearance in text: VWF: M1528V

PubMed Link: 19665675

Variant Present in the following documents:

• Main text

View BVdb publication page